Esperoct Effective Over Long Term in Children With Severe Hemophilia A, Phase 3 Results Show
Long-term treatment with Esperoct (turoctocog alfa pegol) prevented bleeding in one-fifth of children with severe hemophilia…
Articles by Patricia Inácio, PhD
‘Advancements’ TV Show to Feature State-of-the-Art Research in Bleeding Disorders
An upcoming episode of the TV series “Advancements,” hosted by Ted Danson, will be dedicated to current and future…
National Hemophilia Foundation Offering Grants to Bleeding Disorder Groups
The National Hemophilia Foundation (NHF) has opened a grant program to support the local groups and chapters that work…
FVIII Prophylaxis Early in Life Improves Joint Outcomes in Hemophilia A, Study Shows
Starting factor VIII (FVIII) preventive therapy before the age of 2.5 years improves joint outcomes in young adults with…
DalcA Shows Sustained Efficacy in Hemophilia B in Trial
Under-the-skin, preventive treatment with Dalcinonacog alfa (DalcA) led to sustained and protective levels of factor IX (FIX) in people with…
EU Patients Satisfied with Treatment and Physically Active, Survey Finds
Europeans with severe hemophilia are largely satisfied with available treatments and able to maintain active lives, according to a survey…
Prophylaxis Better Than On-demand Therapy for Reducing Bleeds in Hemophilia A, Study Reports
Switching from on-demand to preventive treatment — or prophylaxis — significantly reduces bleeding in adults…
Blood Evident in Urine Linked to Hypertension in Patients with Family History
Blood visibly present in urine — called macroscopic hematuria — considerably increases the risk of hypertension in hemophilia…
Blood Type, Von Willebrand Factor Play No Role in FVIII Levels in Non-Severe Hemophilia A, Study Suggests
In contrast to observations in the general population, blood type and levels of von Willebrand factor (VWF) don’t appear…
Novo Nordisk Offers Assurances on Hemophilia Therapy Supplies, Aid to Patients
Novo Nordisk reports that its treatments for hemophilia and other disorders remain available, and it is taking measures…